Location: Canada, Quebec, Montreal
Employees: 1-10
Total raised: $2.2M
Founded date: 2015
Funding Rounds 1
| Date | Series | Amount | Investors |
| 23.06.2023 | - | $2.2M | Investisse... |
Mentions in press and media 4
| Date | Title | Description |
| 04.09.2024 | NeuroServo appoints Dr Andrew J. Cole as Chief Medical Officer | VEEGix8, 8 channels EEG NeuroServo, developing an instant-use EEG with AI pathology assessment, announced that Dr Andrew Cole has been appointed Chief Medical Officer and board member. MONTREAL, QC, CANADA, September 4, 2024 /EINPresswire.c... |
| 23.06.2023 | NeuroServo Closes $2.2M Funding Round | NeuroServo, a Montreal, Canada-based medical device company raised $2.2M in funding. The round was led by Desjardins Capital, Investissement Québec, CABHI as well as private investors. The company intends to use the funds to finance the com... |
| 22.02.2021 | NeuroServo receives certification for its EEG device and for the company as a medical manufacturer | MONTREAL (PRWEB) February 22, 2021 NeuroServo, an early stage medical device company developing an advanced portable and wireless prefrontal EEG announced today that the company received ISO 13485:2016 certification for its R&D and prod... |
| - | NeuroServo | “NeuroServo – NeuroServo” |